AMP
43
2
SYK
50
4
CF
47
5
DOV
48
2
WAT
55
11
PWR
63
3
CTAS
36
8
EW
55
5
DLTR
52
8
ABBV
40
5
DGX
28
4
JCI
44
7
AKAM
50
2
NSC
33
6
KO
44
2
RF
44
10
EMR
57
7
UAL
73
3
ES
12
3
CVS
27
2
AMP
43
2
SYK
50
4
CF
47
5
DOV
48
2
WAT
55
11
PWR
63
3
CTAS
36
8
EW
55
5
DLTR
52
8
ABBV
40
5
DGX
28
4
JCI
44
7
AKAM
50
2
NSC
33
6
KO
44
2
RF
44
10
EMR
57
7
UAL
73
3
ES
12
3
CVS
27
2
Financhill
Back

Bicycle Therapeutics PLC 10K Form

Sell
2

BCYC
Bicycle Therapeutics PLC

Last Price:
$14.70
Seasonality Move:
10.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-11-05 10Q BCYC/Bicycle Therapeutics PLC Quarterly
2020-08-05 10Q BCYC/Bicycle Therapeutics PLC Quarterly
2020-05-07 10Q BCYC/Bicycle Therapeutics PLC Quarterly
2020-03-10 10K BCYC/Bicycle Therapeutics PLC Annual
2019-11-07 10Q BCYC/Bicycle Therapeutics PLC Quarterly
2019-08-08 10Q BCYC/Bicycle Therapeutics PLC Quarterly

Receive BCYC News And Ratings

See the #1 stock for the next 7 days that we like better than BCYC

BCYC Financial Statistics

Sales & Book Value

Annual Sales: $27M
Cash Flow: $-40.3M
Price / Cash Flow: 0
Annual Sales: $12.04
Price / Book: 1.22

Profitability

EPS (TTM): -3.29000
Net Income (TTM): $-166.3M
Gross Margin: --
Return on Equity: -29.19%
Return on Assets: -21.68%

Bicycle Therapeutics PLC Earnings Forecast

Key Bicycle Therapeutics PLC Financial Ratios

  • The Research & Development expenses have been 580.13% of Revenue.
  • The Interest Expense is -1.81% of Operating Income.
  • The Net Earning history of BCYC is -669.72% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Bicycle Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BCYC
CUSIP: 088786
Website: bicycletherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 17.13
Quick Ratio: 16.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BCYC Technical Analysis vs Fundamental Analysis

Sell
2
Bicycle Therapeutics PLC (BCYC) is a Sell

Is Bicycle Therapeutics PLC a Buy or a Sell?